Stanley-Laman Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,809
| Closed | -$321K | – | 295 |
|
|
2016
Q1 | $321K | Hold |
4,809
| – | – | 0.06% | 207 |
|
|
2015
Q4 | $325K | Hold |
4,809
| – | – | 0.06% | 259 |
|
|
2015
Q3 | $257K | Hold |
4,809
| – | – | 0.05% | 261 |
|
|
2015
Q2 | $303K | Hold |
4,809
| – | – | 0.06% | 247 |
|
|
2015
Q1 | $231K | Buy |
+4,809
| New | +$231K | 0.04% | 278 |
|
|
2014
Q2 | – | Sell |
-4,809
| Closed | -$202K | – | 297 |
|
|
2014
Q1 | $202K | Buy |
+4,809
| New | +$202K | 0.04% | 306 |
|